Best Asian Stocks To Own For 2014

Source: thinkstockAugust 21, 2013: Markets opened mixed this morning as traders and investors waited for the afternoon�� release of the July FOMC meeting minutes. Existing home sales rose more than expected in July. A report on mortgage applications showed a decline, however, as interest rate increases continue to slow the number of refinancings. The U.S. crude inventory fell last week, and crude spot prices for October delivery dropped 1.2% today to $103.85.

European closed lower today, while Latin American and Asian markets markets closed mixed.

The FOMC minutes did not reveal anything unexpected. But then, they never really do. Markets reacted with a buying spurt on the inference that the Fed�� asset purchases wouldn�� stop next month, but the uptick was short-lived.

Top 10 Mid Cap Stocks To Buy Right Now: Integrated Device Technology Inc. (IDTI)

Integrated Device Technology, Inc. designs, develops, manufactures, and markets a range of integrated circuits for communications, computing, and consumer industries worldwide. It operates in two segments, Communications, and Computing and Consumer. The Communications segment offers communication clocks, digital logic products, first in and first out memories, serial RapidIO solutions for wireless base station infrastructure applications, integrated communications processors, static random access memory products, radio frequency products, and telecommunications semiconductor products. This segment markets its products to the enterprise, data center, and wireless markets. The Computing and Consumer segment provides timing products, PCI Express switching and bridging solutions, high-performance server memory interfaces, multi-port products, touch controllers, signal integrity products, and PC audio and video products. This segment?s computing products are designed for deskto p, notebook, sub-notebook, storage, and server applications; and consumer products are optimized primarily for gaming consoles, set-top boxes, digital TV, and smart phones. The company markets its products primarily to original equipment manufacturers through various channels, including a direct sales force, distributors, electronic manufacturing suppliers, and independent sales representatives. Integrated Device Technology, Inc. was founded in 1980 and is headquartered in San Jose, California.

Advisors' Opinion:

• [By GuruFocus]

  
  Integrated Device Technology (IDTI): Interim President and CEO Jeffrey Stephen McCreary Bought 60,000 Shares

  Interim President and CEO of Integrated Device Technology (IDTI) Jeffrey Stephen McCreary bought 60,000 shares during the past week at an average price of $8.72. Integrated Device Technology was incorporated in California in 1980 and reincorporated in Delaware in 1987. Integrated Device Technology has a market cap of $1.31 billion; its shares were traded at around $8.72 with a P/E ratio of 39.00 and P/S ratio of 2.66.

• [By iStockAnalyst]

  Integrated Device Technology Inc. (NASDAQ:IDTI) will issue first quarter 2015 financial results on July 28, 2014 after 1:00 p.m. Pacific time. The financial results webcast will begin at 1:30 p.m.

Best Asian Stocks To Own For 2014: Luminex Corporation(LMNX)

Luminex Corporation engages in the development, manufacture, and sale of proprietary biological testing technologies and products for the life sciences and diagnostic industries. It offers xMAP technology, an open architecture and multiplexing technology that allows simultaneous analysis of approximately 500 bioassays from a drop of fluid by reading biological tests on the surface of microscopic polystyrene beads called microspheres. The company?s xMAP technology is used in various segments of the life sciences industry, such as the fields of drug discovery and development, clinical diagnostics, genetic analysis, bio-defense, food safety, and biomedical research. It operates in two segments, Technology and Strategic Partnerships; and Assays and Related Products. The Technology and Strategic Partnerships segment provides Luminex LX 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; and MAGP IX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids. This segment also offers consumables comprising dyed polystyrene microspheres and sheath fluids. The Assays and Related Products segment develops and sells assays on xMAP technology for use on its installed base of systems. This segment?s products are focused on the human genetics, personalized medicine, and infectious disease segments of the genetic testing market. This segment provides various assay products, which consist of a combination of chemical and biological reagents, and company?s proprietary bead technology used to perform diagnostic and research assays on samples. It serves pharmaceutical companies, clinical laboratories, research institutions, and medical institutions in the United States, Europe, Asia, Canada, and Australia. The company was founded in 1995 and is headquartered in Austin, Texas.

Advisors' Opinion:

• [By Seth Jayson]

  There's no foolproof way to know the future for Luminex (Nasdaq: LMNX  ) or any other company. However, certain clues may help you see potential stumbles before they happen -- and before your stock craters as a result.

• [By Markus Aarnio]

  Illumina's competitors include Affymetrix (AFFX), Life Technologies Corporation (LIFE) and Luminex Corporation (LMNX). Here is a table comparing these companies.

Best Asian Stocks To Own For 2014: Madison Square Garden Inc.(MSG)

The Madison Square Garden Company, together with its subsidiaries, operates in the sports, entertainment, and media businesses primarily in the United States. The company operates in three segments: MSG Media, MSG Entertainment, and MSG Sports. The MSG Media segment produces and develops content for various distribution platforms, including content originating from the company?s venues. It consists of the MSG Networks and the Fuse Networks, which offer sports and musical content. This segment also manages interactive businesses that comprise a range of targeted websites; and wireless, video on demand, and digital platforms. The MSG Entertainment segment creates, produces, and/or presents various live productions, as well as presents or hosts other live entertainment events, such as concerts, family shows, special events, and theatrical productions. The MSG Sports segment owns and operates sports franchises. This segment also owns other sports properties, including the pre sentation of a range of live sporting events, such as professional boxing, college basketball, track and field, and tennis. The company owns the Madison Square Garden complex in New York City, which includes an arena and a theater; and The Chicago Theatre in Chicago. It leases Radio City Music Hall and the Beacon Theatre in New York City. The company is based in New York, New York. As of February 09, 2010, Madison Square Garden, Inc. operates independently of Cablevision Systems Corporation.

Advisors' Opinion:

• [By Ben Levisohn]

  Another important component of overcrowding is that current volatility tends to be low, and underestimates the amount of risk in the stock, Zlotnikov says. He offers a list of low-beta stocks that screened for overcrowding characteristics. They include Walt Disney (DIS), Ecolab (ECL), Walgreen (WAG), McKesson (MCK) and Madison Square Garden (MSG), among others.

• [By Sue Chang]

  Madison Square Garden Co. (MSG) �is forecast to post fiscal first-quarter earnings of 21 cents a share.

• [By Ian Wyatt, Publisher & Chief Investment Strategist, Wyatt Investment Research]

  Meanwhile, Mark Boyar, of The Boyar Value Fund, recommends another household name: Madison Square Garden (MSG). He thinks the Dolan family could take the company private.

Best Asian Stocks To Own For 2014: Norsk Hydro ASA (NHY)

Norsk Hydro ASA is a Norway-based company engaged in a number of activities along the aluminum industry�� value chain. The Company is organized into six segments; the Bauxite & Alumina segment includes the Company�� mining activities, sourcing arrangements and alumina commercial operations; the Primary Metal segment consists of aluminum production, re-melting and casting activities; the Metal Markets segment includes sales and distribution activities relating to products from metal plants, metal sourcing and trading activities; the Rolled Products segment comprises operations of the Company�� rolling mills; the Extruded Products segment focuses on delivering solutions to the building and construction, transportation, and engineered products industries and includes aluminum building systems and precision tubing activities, and the Energy segment is responsible for managing the Company�� captive hydropower production and external power sourcing arrangements to the aluminum business. Advisors' Opinion:

• [By Corinne Gretler]

  Norsk Hydro (NHY) ASA slumped the most in one year after Vale SA sold a stake in the aluminum maker. UniCredit SpA (UCG) and Infineon Technologies AG added at least 1 percent each after posting quarterly profit that beat projections. Henkel AG rose 2.1 percent as third-quarter profit beat analysts��estimates.

Best Asian Stocks To Own For 2014: ONYX Pharmaceuticals Inc.(ONXX)

Onyx Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies that target the molecular mechanisms that cause cancer in the United States and internationally. The company, through its collaboration agreement with Bayer HealthCare Pharmaceuticals, Inc., develops and markets Nexavar (sorafenib) tablet, a multiple kinase inhibitor for the treatment of liver cancer and advanced kidney cancer. It is also conducting Phase III clinical trial on Nexavar for the treatment of kidney, liver, lung, thyroid, breast, and non-small cell lung cancers; clinical trials on carfilzomib, a proteasome inhibitor for the treatment of patients with relapsed or relapsed/refractory multiple myeloma and solid tumors; and Phase Ib/II clinical trial on Oprozomib, an oral proteasome inhibitor. In addition, Onyx Pharmaceuticals, Inc. is developing ONX 0914, an immunoproteasome inhibitor, which is in preclinical stage for the treatment of autoimmune disorders, such as rheumatoid arthritis, inflammatory bowel disease, and lupus. Further, the company, through its collaboration agreement with Bayer HealthCare Pharmaceuticals, Inc., is conducting clinical trials on Regorafenib, a multi-kinase inhibitor to treat metastatic colorectal cancer and gastrointestinal stromal tumors. It has a collaboration agreement with Warner-Lambert Company to discover and commercialize small molecule drugs that restore control of or intervene in the misregulated cell cycle in tumor cells. The company also has development and license agreements with BTG International Limited for the development and commercialization of ONX 0801, a novel targeted oncology compound; and Ono Pharmaceutical Co., Ltd. to develop and commercialize carfilzomib and Oprozomib for oncology indications in Japan. Onyx Pharmaceuticals, Inc. was founded in 1992 and is headquartered in South San Francisco, California.

Advisors' Opinion:

• [By Paul Ausick]

  Stocks on the move: Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) is up 5.6% at $123.52 after accepting a $10.4 billion buyout offer from Amgen Inc. (NASDAQ: AMGN). Chinese wealth management firm Noah Holdings Ltd. (NYSE: NOAH) is down 16.6% at $13.76 following an analyst downgrade on worries about the company�� recurring revenues.